NCT00584402View on ClinicalTrials.gov

Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Liver Neoplasms
Interventions
DRUG

perflutren lipid microspheres

perflutren lipid microspheres IV in 0.1 cc doses, as needed, to enhance lesion conspicuity

Trial Locations (1)

95817

UC Davis Medical Center, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT00584402 - Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation | Biotech Hunter | Biotech Hunter